Altimeter Capital and Coatue led a $220m Series D round in Reify Health, a provider of solutions that empower the clinical trial ecosystem, with participation from Dragoneer Investment Group, ICONIQ Growth, Adams Street, and Battery Ventures. "Reify Health is making great strides to ensure patient and provider access to clinical trials is more equitable and diverse, working with key industry leaders and stakeholders. Altimeter is excited to be a part of Reify’s journey to modernize clinical trials and address historical barriers to benefit more people in need faster," Pauline Yang, Altimeter Capital Partner.